Medical Xpress - Cardiology

APRIL 7, 2025

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, in collaboration with researchers across multiple institutions, has published a new study that challenges the long-held belief that high cholesterol correlates and even directly causes coronary artery disease, or plaque buildup in the arteries in metabolically healthy (..)

Cholesterol 49

Cholesterol Research Coronary Artery Disease Diet 49

DAIC

JANUARY 8, 2024

GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world.

Innovation 105

Innovation Technology Patient Care Coronary Artery Disease 105

DAIC

APRIL 12, 2024

This breakthrough device is poised to significantly change the approach to treating coronary CTOs by providing real-time optical coherence tomography (OCT) visualization, enabling precise guidewire placement within the target vessel's true lumen and subsequent revascularization.

Technology 111

Technology Cardiovascular Interventions Coronary Artery Disease Innovation 111

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. The DynamX bioadaptor has a novel design and mechanism of action designed to return the diseased vessel to a more normal condition, through three distinct phases.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

JANUARY 15, 2024

FDA Breakthrough Device Designation recognizes novel innovations that demonstrate the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases. For more information: [link] References: 1 Maurer M, Elliott P, Comenzo R, et al.

Ultrasound 119

Ultrasound Coronary Artery Disease Innovation Heart Failure 119

DAIC

JUNE 25, 2024

milla1cf Tue, 06/25/2024 - 18:58 June 25, 2024 — Nano-X Imaging (Nanox), an innovative medical imaging technology company, today announced that data from five studies supporting the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox AI, will be presented at the 19th Annual Meeting of the Society of Cardiovascular Computed Tomography ( SCCT (..)

Coronary Artery Disease 105

Coronary Artery Disease Hospital Innovation Technology 105

DAIC

JANUARY 3, 2024

6 Also in 2023, HeartFlow released its RoadMap Analysis which helps identify and quantify narrowings in the coronary arteries and has demonstrated a 25% faster CCTA read time. HeartFlow is committed to serving customers quickly and reliably with a median turnaround time less than 1.5

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

DAIC

JANUARY 17, 2024

At present, machine learning, deep learning, and other AI technologies have been tried to be applied to intelligent diagnostic and decision making, image interpretation, accurate classification, and prognostication of cardiovascular diseases, which has led to broad application prospects and innovation potential.

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

DAIC

APRIL 3, 2024

Featured topics will include in-depth sessions covering non-statin lipid lowering therapies, heart failure with preserved ejection fraction, viability, imaging modalities for the assessment of coronary artery disease, and antiplatelet therapy after coronary stenting. Too Many Choices? 24 news here.

Education 105

Education Preserved Ejection Fraction Coronary Artery Disease Cardio Oncology 105

DAIC

MARCH 6, 2024

milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.

Heart Disease 105

Heart Disease Heart attacks Heart Attack Technology 105

DAIC

JUNE 27, 2024

Attendees can join with their peers and participate in sessions on structural heart disease, congenital heart disease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heart disease, debates and games and early career topics. for all attendees.

Congenital Heart Disease 105

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease 105

DAIC

MARCH 11, 2024

A prospective multi-center clinical study of the device is scheduled to begin enrollment this year. “We have many interventional or surgical revascularization options for patients with advanced large coronary artery disease. However, a significant proportion still suffer from angina. VahatiCor, Inc.,

Angina 59

Angina Innovation Heart Disease Chest Pain 59

DAIC

JANUARY 8, 2024

He was diagnosed with extensive coronary artery disease, resulting in ischemic cardiomyopathy and heart failure. His heart was weak and did not pump well due to blockages in his coronary arteries. David Gibson, 75, of Walbridge, Ohio, traveled 100 miles to undergo care with UH Harrington Heart & Vascular Institute.

Bicuspid/Mitral 124

Bicuspid/Mitral Atrial Fibrillation Anatomy Coronary Artery Disease 124

Heart 2023 Conference

JANUARY 17, 2024

This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Koonlawee Nademanee, Director of the Bumrungrad Heart Institute in Thailand, have spearheaded the establishment of a world-class heart institute.

Congenital Heart Disease 49

Congenital Heart Disease Coronary Artery Disease Heart Transplant Transplant 49

DAIC

SEPTEMBER 10, 2024

The results of our validation studies show this innovative test demonstrates outstanding intra (2 percent) and inter (10 percent) test variation, well below the current FDA guidance (25 percent)," said Dr. David Schneider Prolocor Co-Founder and Chief Science Officer. tim.hodson Tue, 09/10/2024 - 13:34 Sept. 5,2024 - Prolocor, Inc.

Thrombosis 52

Thrombosis Coronary Artery Disease Stents Stent 52

Circulation

JANUARY 15, 2024

Coronary artery calcification (CAC) accompanies the development of advanced atherosclerosis. These innovations may speed achieving the ultimate goal of providing noninvasively specific and clinically actionable information.

Coronary Artery Disease 45

Coronary Artery Disease Atherosclerosis Laboratory Plaque 45

ADN Center of Excellence

OCTOBER 7, 2024

Interventional cardiology has dramatically evolved over the past decades, introducing advanced techniques and tools that have revolutionized the treatment of coronary artery disease, valvular disorders, and structural heart diseases. What’s New in Approaches and Solutions?

Interventional Cardiology 59

Interventional Cardiology Coronary Artery Disease Innovation Anatomy 59

ADN Center of Excellence

OCTOBER 7, 2024

Interventional cardiology has dramatically evolved over the past decades, introducing advanced techniques and tools that have revolutionized the treatment of coronary artery disease, valvular disorders, and structural heart diseases. What’s New in Approaches and Solutions?

Interventional Cardiology 52

Interventional Cardiology Coronary Artery Disease Innovation Anatomy 52

Cardiometabolic Health Congress

AUGUST 2, 2024

This innovative approach integrates personal data from multiple biological layers to design bespoke dietary plans, transcending the limitations of one-size-fits-all recommendations. How can genetically tailored nutrition impact cardiovascular health? Is precision nutrition widely available?

Diet 59

Diet Technology Coronary Artery Disease Quality of Life 59

Wellnest

JUNE 19, 2023

With the continued evolution of AI, it is now being introduced in cardiac healthcare, promising opportunities for innovation and advancements in cardiovascular medicine. Alternatively, it also helps enhance arrhythmia management with coronary artery disease. For instance: 1.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

GEMMS

AUGUST 29, 2024

These systems use deep learning techniques to identify subtle deviations in imaging data, such as changes in the structure of the heart or blood vessels, that could indicate the presence of disease. Reach out today to learn more about our innovative solutions and how they can transform your practice.

Technology 52

Technology Patient Care Outcomes Coronary Artery Disease 52

DAIC

MAY 14, 2024

Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

DECEMBER 5, 2024

Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. Cleerly’s pioneering approach to advanced cardiovascular imaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronary artery disease.

Coronary Artery Disease 52

Coronary Artery Disease Medicare Plaque Technology 52

DAIC

MARCH 28, 2025

v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

DAIC

MARCH 31, 2025

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J. Budoff, M.D.,

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart attacks 52

DAIC

MAY 31, 2024

Joaquin Duato , Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally.

Peripheral Arterial Disease 104

Peripheral Arterial Disease Innovation Coronary Artery Disease Cardiovascular Interventions 104

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years. 101272, [link].

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

APRIL 5, 2024

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

DAIC

JUNE 12, 2024

The new FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds.

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105

DAIC

MARCH 20, 2024

Lowering both contrast and radiation levels enables more frequent scanning for patients with moderate or stage two and three coronary artery disease. However, when we conducted an in-office coronary CT angiogram, it revealed blockages in all three blood vessels, despite prior assurance of normal arteries.

Technology 111

Technology Coronary Artery Disease Patient Care Private Practice 111

DAIC

MARCH 27, 2024

The company reports this broadens the use of the novel bioadaptor platform technology beyond the treatment of coronary artery disease. The Bioadaptor platform was developed to transform treatment of coronary and peripheral artery disease,” said Motasim Sirhan, CEO at Elixir Medical , based in Milpitas, CA.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Ischemia Technology Coronary Artery Disease 111

DAIC

MARCH 31, 2025

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J. Budoff, M.D.,

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart attacks 52

DAIC

MARCH 1, 2024

Those who had ventricular fibrillation were more likely to be younger, have had coronary artery disease or experienced chest pain as a warning symptom. “We “We plan to continue to study this AI method to learn how it could be used in a clinical setting.”

Cardiac Arrest 111

Cardiac Arrest Electrocardiogram Defibrillator Electrophysiology 111

DAIC

MARCH 7, 2024

I think especially with the recent changes in guidelines and the recommendation to use CT for screening of coronary artery disease, we expect to see this trend really impact the way CT is used in the future.” “The CT procedural mix is evolving, and cardiac CT is starting to account for a large proportion of that.

Technology 111

Technology Document Cardiovascular Imaging Cancer 111

ADN Center of Excellence

SEPTEMBER 28, 2023

The Role of Cardiologists Cardiologists are at the forefront of the battle against heart diseases. Their expertise covers a wide range of cardiovascular conditions, including coronary artery disease, heart failure, arrhythmias, and congenital heart defects.

COVID-19 52

COVID-19 Heart Disease Education Interventional Cardiology 52

Cardiomatics

AUGUST 4, 2022

According to WHO , cardiovascular diseases are the leading cause of death worldwide – it is estimated that they are the cause of 17.9 Cardiovascular diseases are a group of diseases of the heart and blood vessels. They include coronary artery disease, cerebrovascular disease, and rheumatic heart disease.

Cardiovascular Disease 52

Cardiovascular Disease Technology COVID-19 Coronary Artery Disease 52

Journal of the American Heart Association

FEBRUARY 23, 2024

BackgroundRegardless of progress in treatment of coronary artery disease (CAD), there is still a significant residual risk of death in patients with CAD, highlighting the need for additional risk stratification markers. Journal of the American Heart Association, Ahead of Print.

Coronary Artery Disease 67

Coronary Artery Disease Sudden Cardiac Death Blood Pressure Diabetes 67